<?xml version="1.0" encoding="UTF-8"?>
<ref id="B98-molecules-26-00632">
 <label>98.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Sohag</surname>
    <given-names>A.A.M.</given-names>
   </name>
   <name>
    <surname>Hannan</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Rahman</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Hossain</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Hasan</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Khan</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Khatun</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Dash</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Uddin</surname>
    <given-names>J.</given-names>
   </name>
  </person-group>
  <article-title>Revisiting potential druggable targets against SARS-CoV-2 and repurposing therapeutics under preclinical study and clinical trials: A comprehensive review</article-title>
  <source>Drug Dev. Res.</source>
  <year>2020</year>
  <volume>81</volume>
  <fpage>919</fpage>
  <lpage>941</lpage>
  <pub-id pub-id-type="doi">10.1002/ddr.21709</pub-id>
 </element-citation>
</ref>
